Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis
Authors:
- Tamihiro KawakamiTKTamihiro Kawakami
- Kyoko KaminishiKKKyoko Kaminishi
- Yoshinao SomaYSYoshinao Soma
- Tsuneto KushimotoTKTsuneto Kushimoto
- Masako MizoguchiMMMasako Mizoguchi
- 31 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 43 (2) , 127-134
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Neurophysiological evidence for altered sensory function caused by storage of hydroxyethyl starch in cutaneous nerve fibresBritish Journal of Dermatology, 2005
- Mast cell tryptase: a review of its physiology and clinical significanceAnaesthesia, 2004
- Skin concentrations of H1-receptor antagonistsJournal of Allergy and Clinical Immunology, 2001
- Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticariaAnnals of Allergy, Asthma & Immunology, 2000
- A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Efficacy and Safety of Fexofenadine Hydrochloride for Treatment of Seasonal Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997
- MANAGING ADULTS WITH ATOPIC DERMATITISDermatologic Clinics, 1996
- Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseasesJournal of Allergy and Clinical Immunology, 1995
- Granulocyte Recruitment by Human Mast Cell TryptaseInternational Archives of Allergy and Immunology, 1995